United States Gout Drugs Market Report 2017

United States Gout Drugs Market Report 2017

1 Gout Drugs Overview

1.1 Product Overview and Scope of Gout Drugs

1.2 Classification of Gout Drugs by Product Category

1.2.1 United States Gout Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Gout Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Allopurinol

1.2.4 Colchicine

1.2.5 Probenecid

1.2.6 Others

1.3 United States Gout Drugs Market by Application/End Users

1.3.1 United States Gout Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Family

1.4 United States Gout Drugs Market by Region

1.4.1 United States Gout Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Gout Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Gout Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Gout Drugs Status and Prospect (2012-2022)

1.4.5 New England Gout Drugs Status and Prospect (2012-2022)

1.4.6 The South Gout Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Gout Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Gout Drugs (2012-2022)

1.5.1 United States Gout Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Gout Drugs Revenue and Growth Rate (2012-2022)

2 United States Gout Drugs Market Competition by Players/Suppliers

2.1 United States Gout Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Gout Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Gout Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Gout Drugs Market Competitive Situation and Trends

2.4.1 United States Gout Drugs Market Concentration Rate

2.4.2 United States Gout Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Gout Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Gout Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Gout Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Gout Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Gout Drugs Price by Region (2012-2017)

4 United States Gout Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Gout Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Gout Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Gout Drugs Price by Type (2012-2017)

4.4 United States Gout Drugs Sales Growth Rate by Type (2012-2017)

5 United States Gout Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Gout Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Gout Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Gout Drugs Players/Suppliers Profiles and Sales Data

6.1 Sun Pharma

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Gout Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Sun Pharma Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Mylan

6.2.2 Gout Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Mylan Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Apotex

6.3.2 Gout Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Apotex Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Northstar

6.4.2 Gout Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Northstar Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Ipca

6.5.2 Gout Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Ipca Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Accord

6.6.2 Gout Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Accord Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Synpac-Kingdom

6.7.2 Gout Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Synpac-Kingdom Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 PIDI

6.8.2 Gout Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 PIDI Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 KPC

6.9.2 Gout Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 KPC Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Yunnan Phytopharmaceutical

6.10.2 Gout Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Gout Drugs Manufacturing Cost Analysis

7.1 Gout Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Gout Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Gout Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Gout Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Gout Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Gout Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Gout Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Gout Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Gout Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Gout Drugs

Figure United States Gout Drugs Market Size (K Pcs) by Type (2012-2022)

Figure United States Gout Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Allopurinol Product Picture

Figure Colchicine Product Picture

Figure Probenecid Product Picture

Figure Others Product Picture

Figure United States Gout Drugs Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Gout Drugs by Application in 2016

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Family Examples

Table Key Downstream Customer in Family

Figure United States Gout Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Gout Drugs Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Gout Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Gout Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Gout Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Gout Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Gout Drugs Sales Share by Players/Suppliers

Figure 2017 United States Gout Drugs Sales Share by Players/Suppliers

Figure United States Gout Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Gout Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Gout Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Gout Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Gout Drugs Revenue Share by Players/Suppliers

Table United States Market Gout Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Gout Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Gout Drugs Market Share of Top 3 Players/Suppliers

Figure United States Gout Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Gout Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Gout Drugs Product Category

Table United States Gout Drugs Sales (K Pcs) by Region (2012-2017)

Table United States Gout Drugs Sales Share by Region (2012-2017)

Figure United States Gout Drugs Sales Share by Region (2012-2017)

Figure United States Gout Drugs Sales Market Share by Region in 2016

Table United States Gout Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Gout Drugs Revenue Share by Region (2012-2017)

Figure United States Gout Drugs Revenue Market Share by Region (2012-2017)

Figure United States Gout Drugs Revenue Market Share by Region in 2016

Table United States Gout Drugs Price (USD/Pcs) by Region (2012-2017)

Table United States Gout Drugs Sales (K Pcs) by Type (2012-2017)

Table United States Gout Drugs Sales Share by Type (2012-2017)

Figure United States Gout Drugs Sales Share by Type (2012-2017)

Figure United States Gout Drugs Sales Market Share by Type in 2016

Table United States Gout Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Gout Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Gout Drugs by Type (2012-2017)

Figure Revenue Market Share of Gout Drugs by Type in 2016

Table United States Gout Drugs Price (USD/Pcs) by Types (2012-2017)

Figure United States Gout Drugs Sales Growth Rate by Type (2012-2017)

Table United States Gout Drugs Sales (K Pcs) by Application (2012-2017)

Table United States Gout Drugs Sales Market Share by Application (2012-2017)

Figure United States Gout Drugs Sales Market Share by Application (2012-2017)

Figure United States Gout Drugs Sales Market Share by Application in 2016

Table United States Gout Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Gout Drugs Sales Growth Rate by Application (2012-2017)

Table Sun Pharma Basic Information List

Table Sun Pharma Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sun Pharma Gout Drugs Sales Growth Rate (2012-2017)

Figure Sun Pharma Gout Drugs Sales Market Share in United States (2012-2017)

Figure Sun Pharma Gout Drugs Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mylan Gout Drugs Sales Growth Rate (2012-2017)

Figure Mylan Gout Drugs Sales Market Share in United States (2012-2017)

Figure Mylan Gout Drugs Revenue Market Share in United States (2012-2017)

Table Apotex Basic Information List

Table Apotex Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Apotex Gout Drugs Sales Growth Rate (2012-2017)

Figure Apotex Gout Drugs Sales Market Share in United States (2012-2017)

Figure Apotex Gout Drugs Revenue Market Share in United States (2012-2017)

Table Northstar Basic Information List

Table Northstar Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Northstar Gout Drugs Sales Growth Rate (2012-2017)

Figure Northstar Gout Drugs Sales Market Share in United States (2012-2017)

Figure Northstar Gout Drugs Revenue Market Share in United States (2012-2017)

Table Ipca Basic Information List

Table Ipca Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Ipca Gout Drugs Sales Growth Rate (2012-2017)

Figure Ipca Gout Drugs Sales Market Share in United States (2012-2017)

Figure Ipca Gout Drugs Revenue Market Share in United States (2012-2017)

Table Accord Basic Information List

Table Accord Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Accord Gout Drugs Sales Growth Rate (2012-2017)

Figure Accord Gout Drugs Sales Market Share in United States (2012-2017)

Figure Accord Gout Drugs Revenue Market Share in United States (2012-2017)

Table Synpac-Kingdom Basic Information List

Table Synpac-Kingdom Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Synpac-Kingdom Gout Drugs Sales Growth Rate (2012-2017)

Figure Synpac-Kingdom Gout Drugs Sales Market Share in United States (2012-2017)

Figure Synpac-Kingdom Gout Drugs Revenue Market Share in United States (2012-2017)

Table PIDI Basic Information List

Table PIDI Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure PIDI Gout Drugs Sales Growth Rate (2012-2017)

Figure PIDI Gout Drugs Sales Market Share in United States (2012-2017)

Figure PIDI Gout Drugs Revenue Market Share in United States (2012-2017)

Table KPC Basic Information List

Table KPC Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure KPC Gout Drugs Sales Growth Rate (2012-2017)

Figure KPC Gout Drugs Sales Market Share in United States (2012-2017)

Figure KPC Gout Drugs Revenue Market Share in United States (2012-2017)

Table Yunnan Phytopharmaceutical Basic Information List

Table Yunnan Phytopharmaceutical Gout Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Yunnan Phytopharmaceutical Gout Drugs Sales Growth Rate (2012-2017)

Figure Yunnan Phytopharmaceutical Gout Drugs Sales Market Share in United States (2012-2017)

Figure Yunnan Phytopharmaceutical Gout Drugs Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Gout Drugs

Figure Manufacturing Process Analysis of Gout Drugs

Figure Gout Drugs Industrial Chain Analysis

Table Raw Materials Sources of Gout Drugs Major Players/Suppliers in 2016

Table Major Buyers of Gout Drugs

Table Distributors/Traders List

Figure United States Gout Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Gout Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Gout Drugs Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Gout Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Gout Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Gout Drugs Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Gout Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Gout Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Gout Drugs Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Gout Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Gout Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Gout Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Gout Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources